Skip to main content
TipRanks
Go Ultimate75% OFF

Laurie Keating Insider Profile

4 Followers

Laurie Keating, Director at Kalaris Therapeutics, holds ― shares in Kalaris Therapeutics (Ticker: KLRS), holds 4.17K shares in PepGen Inc. (Ticker: PEPG), holds 14.00K shares in Immuneering (Ticker: IMRX).

Laurie Keating's Trading History

PEPG
PepGen Inc.
Jan 19, 2023DirectorInformative Buy49.99K$17.46K
IMRX
Immuneering
May 17, 2022DirectorInformative Buy35.00K$49.28K
ALNY
Alnylam Pharma
Aug 09, 2021EVP, Chief Legal OfficerUninformative Buy889.50K$889.06K
ALKS
Alkermes
Jan 03, 2018SVP, GC & SecUninformative Buy232.20K$686.64K
IMGO
Imago BioSciences
――――
KLRS
Kalaris Therapeutics
―Director――

You May Also Like

Laurie Keating insider profile FAQ

What is the percentage of profitable transactions made by Laurie Keating?
The percentage of profitable transactions made by Laurie Keating is 40%.
What is the average return per transaction made by Laurie Keating?
The average return per transaction made by Laurie Keating is -7.70%.
What stocks does Laurie Keating hold?
Laurie Keating holds: KLRS, ALKS, ALNY, IMGO, IMRX, PEPG stocks.
What was Laurie Keating's most profitable transaction?
Laurie Keating’s most profitable transaction was an Informative Buy of IMRX stock on May 17, 2022. The return on the trade was 71.10%.
What is Laurie Keating's role in Kalaris Therapeutics?
Laurie Keating's role in Kalaris Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.